Larvol Veri

BIOMARKER:

RET mutation

Entrez ID:

Related biomarkers:

‹

›

RET mutation RET mutation	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	pralsetinib Sensitive: A1 - Approval CStone Pharma Press Release - 1 week pralsetinib Sensitive : A1 CStone Pharma Press Release - 1wk
RET mutation RET mutation	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	selpercatinib Sensitive: A1 - Approval ISPOR 2021 - 3 weeks selpercatinib Sensitive : A1 ISPOR 2021 - 3wk
RET mutation RET mutation	Thyroid Gland Anaplastic Carcinoma Thyroid Gland Anaplastic Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET mutation RET mutation	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	TPX 0046 Sensitive: C2 – Inclusion Criteria TPX 0046 Sensitive : C2
RET mutation RET mutation	Non Small Cell Lung Cancer NSCLC	TPX 0046 Sensitive: C2 – Inclusion Criteria TPX 0046 Sensitive : C2
RET mutation RET mutation	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	LDD-2633 Sensitive: D – Preclinical LDD-2633 Sensitive : D
RET mutation RET mutation	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	RTB101 + RAF265 Sensitive: D – Preclinical RTB101 + RAF265 Sensitive : D
RET mutation RET mutation	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	TAK-228 + AST-487 Sensitive: D – Preclinical TAK-228 + AST-487 Sensitive : D
RET mutation RET mutation	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	AST-487 Sensitive: D – Preclinical AST-487 Sensitive : D

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and